Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PF4/heparin complexes are T cell-dependent antigens.

Shayela Suvarna1, Lubica Rauova, Emily K E McCracken

  • 1Division of Hematology, DUMC Box 3486, Rm 301 Alex H. Sands Bldg, Research Dr, Durham, NC 27710, USA.

Blood
|April 23, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder.

Blood·2026
Same author

Non-PF4/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia.

Blood·2026
Same author

Novel RHCE*cE(341A) allele.

Transfusion·2026
Same author

Concomitant COX-1 and COX-2 suppression is not sufficient to induce enteropathy associated with chronic NSAID use.

The Journal of clinical investigation·2026
Same author

Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder.

bioRxiv : the preprint server for biology·2025

Heparin-induced thrombocytopenia (HIT) involves autoantibodies against platelet factor 4 (PF4)/heparin. This study shows PF4/heparin complexes trigger these antibodies via a T cell-dependent immune response.

Area of Science:

  • Immunology
  • Hematology
  • Thrombosis

Background:

  • Heparin-induced thrombocytopenia (HIT) is a severe thrombotic condition.
  • HIT is linked to autoantibodies targeting platelet factor 4 (PF4)/heparin complexes.
  • The initiation mechanisms of HIT autoantibody formation remain unclear.

Purpose of the Study:

  • To investigate the immunogenic properties of PF4/heparin complexes.
  • To determine the cellular requirements for initiating the immune response in HIT.
  • To delineate the mechanisms of autoantibody formation in HIT.

Main Methods:

  • Immunization of euthymic and athymic mice with murine PF4 (mPF4)/heparin complexes.
  • Administration of mPF4, heparin, or buffer as controls.
  • Assessment of antibody development and platelet activation.

Related Experiment Videos

Main Results:

  • Mice injected with mPF4/heparin developed heparin-dependent autoantibodies.
  • These antibodies mimicked human HIT antibodies in binding and platelet activation.
  • Athymic mice, lacking T cell function, did not develop HIT-like antibodies.

Conclusions:

  • PF4/heparin complexes are potent immunogens.
  • Autoantibody formation in HIT requires a T cell-dependent immune response.
  • These findings clarify the initiation of self-reacting antibodies in HIT.